When designed properly, contests are an excellent supplement to the sales compensation plan to create excitement and attention around a particular product and activity. In this blog post, we discuss the do’s and don’t of biopharma contest design.

While sales compensation design for any product launch can be incredibly challenging, it is especially complex for products that treat rare and orphan diseases. In this blog post, we explore three sales compensation pitfalls to avoid for the launch of a rare disease product.

Although the forced rank sales compensation plan is one of the most popular designs utilized for a biopharma product launch, the launch stage is actually the stage in which forced rank does the most harm. In this blog post, we explore why you should avoid forced rank sales compensation plans for a product launch.

Critical to the success of a multi-product bag is ensuring that all products get sufficient attention without taking focus away from the product(s) deemed most important. However, there are number of sales compensation pitfalls that make achieving this very challenging. In this blog post, we outline what they are and how to navigate them.

The two most common sales compensation plan periods adopted in biopharma—quarter and trimester—each have their own set of advantages and disadvantages as well as circumstances for use. In this blog post, we explore the pros and cons of these two plan period types.

Targeting the right physicians for a biopharma product launch is critical to getting the product out of the gates quickly and achieving fast adoption. In this blog post, we explore why your physician segmentation and targeting methodology needs to go beyond standard methodologies to drive sales for a new product launch.

Let’s investigate the limitations of the most common way to score MBOs as well as two innovative scoring strategies that drive superior accountability and performance.

A successful launch is critical to ensuring a product’s longevity in the marketplace. Let’s explore why you shouldn’t adopt some of most common solutions to three sales compensation challenges for product launches.

Sales compensation corrections are often made after the plan period has ended in order to address unforeseen circumstances, but does this actually motivate?